Accéder au contenu
MilliporeSigma

D5322

SigMatrix Serum diluent

Contains 6% recombinant human serum albumin

Synonyme(s) :

Recombinant HSA

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

Changer de vue

A propos de cet article

UNSPSC Code:
12352202
NACRES:
NA.25
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider


Nom du produit

6% SigMatrix Serum diluent,

biological source

synthetic

Quality Level

description

Buffered Recombinant Human Serum Albumin

shipped in

wet ice

storage temp.

2-8°C

General description

This reagent is a 6% recombinant HSA (Human Serum Albumin) in PBS solution, pH 7.4, that can be used as a blank or matrix/diluent for proteinaceous analytes in LC-MS/MS calibrators, controls, or samples.The 6% protein content design is meant to mimic endogenous protein concentration in human serum samples.Beneficially, as the HSA source is recombinant, the matrix should not contain any measurable contaminants typically found in even stripped serum.

Physical form

The product contains 6% recombinant human serum albumin in a PBS solution containing 0.01% ProClin 950 as a preservative.

Preparation Note

For more information on other Sigmatrix products visit the Sigmatrix Selection Guide.
This solution is provided ready to use as a 6% (w/v) Recombinant Human Serum Albumin in Phosphate Buffered Saline, pH 7.4. This formulation has been shown to be appropriate for use as a sample diluent or matrix for preparing calibrants/controls for LC-MS/MS assays.

Legal Information

ProClin is a trademark of LANXESS Corp.


Still not finding the right product?

Explore all of our products under


Classe de stockage

12 - Non Combustible Liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents


Articles

Method development for titer determination of three different monoclonal antibodies - cetuximab, trastuzumab, and universal antibody standard using a Chromolith® WP 300 Protein A column.





Numéro d'article de commerce international

RéférenceGTIN
D5322-1L04061838113467
D5322-50ML04061838113474